We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug Products
    • Books
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Subscription Newsletters
    • Free Newsletters
    • Webinar Training Pass
    • eCFR and Guidances
  • Device Products
    • Books
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Subscription Newsletters
    • Free Newsletters
    • Webinar Training Pass
    • eCFR and Guidances
  • Clinical Products
  • Advertising
  • White Papers
  • Contact Us
  • About Us
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » DEPARTMENT OF JUSTICE, FDA SEIZE MASSAGE PRODUCTS SOLD AS 'MEDICAL' DEVICES

DEPARTMENT OF JUSTICE, FDA SEIZE MASSAGE PRODUCTS SOLD AS 'MEDICAL' DEVICES

June 13, 2006

A company selling massage products as medical devices has drawn the ire of the Department of Justice (DOJ) and the FDA.

In two separate court filings, the U.S. Attorneys General for the Western District of New York and the District of Connecticut allege a Canadian importer, Universal Academy, sold unapproved devices in the U.S. by moving the products through fulfillment centers in Buffalo, N.Y, and Meriden, Conn. The two products, "Dr. Ho's Double Massage" and "Dr. Ho's Muscle Massage," were sold by Universal Academy in Markham, Ontario, and promoted as treatments for serious conditions including diabetic neuropathy, arthritis, migraines and multiple sclerosis, according to the DOJ.

Between August 2005 and January 2006, GRE Fulfillment in Buffalo received 200,000 of the products with an estimated retail value of more than $2.7 million, the DOJ said.

The units were assembled at GRE and transferred to Fosdick Fulfillment Corporation in Meriden, from which they were shipped to consumers throughout the U.S., the agency said.

U.S. Marshals, FDA officials and the State of Connecticut Department of Consumer Protection Drug Control Agents executed a warrant to seize an inventory of the devices valued at more than $1 million from Fosdick June 8, the DOG and FDA announced June 12. The GRE inventory has also been seized, the DOJ said.

KEYWORDS FDAnews Device Daily Bulletin

Upcoming Events

  • 19Jan

    Pharmaceutical Quality Risk Management: Navigating the Intersection Between Regulatory Requirements & Risk Management

  • 21Jan

    Virtual MDSAP Audits in the Era of COVID-19: What to Know and Do to Pass Virtual Audits

  • 26Jan

    Reducing Complexity in Starting Clinical Trials – More Patients, Faster Startup

  • 27Jan

    Medical Device Clinical Trials in China: Latest Regulatory Developments

  • 27Jan

    FDA’s Response to COVID-19: Fundamentals of Obtaining Emergency Use Authorizations

  • 09Feb

    Maintaining Your Risk-Based Cleaning and Disinfectant Programs: Best Practices During COVID-19

Featured Products

  • Biological Risk Evaluation and Management for Medical Devices

  • GMP Inspection Preparation Checklist: A Tool for Internal Auditing

Featured Stories

  • Regeneron logo

    U.S. Government Orders More Supplies of Regeneron’s COVID-19 Antibody Cocktail

  • Siemens Healthineers logo

    Siemens Healthineers COVID Test Gets Additional Sampling Method Clearance

  • COVID-19  Clinical Trial

    Synairgen Initiates Dosing in Late-Stage Trial of Inhaled COVID-19 Therapy

  • Verona Pharma logo

    Verona Pharma Ends Enrollment in Inhaler-Administered COVID-19 Drug Pilot

The Revised ICH E8: A Guide to New Clinical Trial Requirements

Learn More
  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell My Personal Information
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Fax 703.538.7676 – Toll free 888.838.5578

Copyright © 2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing